|
GB9816837D0
(en)
*
|
1998-08-04 |
1998-09-30 |
Zeneca Ltd |
Amide derivatives
|
|
EP1071658B1
(en)
|
1998-04-17 |
2004-06-16 |
Parker Hughes Institute |
Btk inhibitors and methods for their identification and use
|
|
CA2338121A1
(en)
*
|
1998-08-04 |
2000-02-17 |
Astrazeneca Ab |
Amide derivatives useful as inhibitors of the production of cytokines
|
|
EP1115707B1
(en)
*
|
1998-09-25 |
2003-11-12 |
AstraZeneca AB |
Benzamide derivatives and ther use as cytokine inhibitors
|
|
US6306897B1
(en)
|
1999-03-19 |
2001-10-23 |
Parker Hughes Institute |
Calanolides for inhibiting BTK
|
|
ES2367422T3
(es)
|
2001-10-09 |
2011-11-03 |
Amgen Inc. |
Derivados de imidazol como agentes antiinflamatorios.
|
|
MXPA05001804A
(es)
|
2002-08-14 |
2005-05-27 |
Vertex Pharma |
Inhibidores de proteinas cinasas y usos de los mismos.
|
|
SI1569907T1
(sl)
*
|
2002-12-13 |
2016-06-30 |
Ym Biosciences Australia Pty Ltd |
Na nikotinamidu osnovani kinazni inhibitorji
|
|
TW200616974A
(en)
*
|
2004-07-01 |
2006-06-01 |
Astrazeneca Ab |
Chemical compounds
|
|
UY29300A1
(es)
*
|
2004-12-22 |
2006-07-31 |
Astrazeneca Ab |
Compuestos quimicos
|
|
AR053992A1
(es)
|
2004-12-22 |
2007-05-30 |
Astrazeneca Ab |
Compuestos quimicos con actividad anticancerosa, un procedimiento para su preparacion, su uso en la preparacion de medicamentos y composicion farmaceutica.
|
|
RU2368602C2
(ru)
|
2005-01-26 |
2009-09-27 |
Айрм Ллк |
Соединения и композиции в качестве ингибиторов протеинкиназ
|
|
AU2006278627B2
(en)
|
2005-08-08 |
2011-08-18 |
Janssen Pharmaceutica, N.V. |
Thiazolopyrimidine kinase inhibitors
|
|
US7754717B2
(en)
*
|
2005-08-15 |
2010-07-13 |
Amgen Inc. |
Bis-aryl amide compounds and methods of use
|
|
US8101610B2
(en)
*
|
2005-11-14 |
2012-01-24 |
Genentech, Inc. |
Bisamide inhibitors of hedgehog signaling
|
|
US20070155746A1
(en)
|
2005-12-23 |
2007-07-05 |
Kalypsys, Inc. |
Novel substituted pyridinyloxy and pyrimidinyloxy amides useful as inhibitors of protein kinases
|
|
US20090312396A1
(en)
|
2006-07-10 |
2009-12-17 |
Astrazeneca Ab |
Methods for cancer treatment using tak1 inhibitors
|
|
BRPI0622054B8
(pt)
|
2006-09-22 |
2021-05-25 |
Oxford Amherst Llc |
composto e composição farmacêutica
|
|
WO2008144253A1
(en)
*
|
2007-05-14 |
2008-11-27 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
|
TW200906825A
(en)
|
2007-05-30 |
2009-02-16 |
Scripps Research Inst |
Inhibitors of protein kinases
|
|
AU2008282728B2
(en)
|
2007-08-02 |
2012-04-19 |
Amgen Inc. |
Pl3 kinase modulators and methods of use
|
|
EP2508523B2
(en)
|
2007-10-23 |
2019-04-17 |
Teva Pharmaceutical Industries Ltd. |
Polymorphs of dasatinib and process for preparation thereof
|
|
EP2222166B9
(en)
|
2007-12-10 |
2012-11-07 |
Concert Pharmaceuticals Inc. |
Heterocyclic kinase inhibitors
|
|
US8426424B2
(en)
|
2008-05-06 |
2013-04-23 |
Cgi Pharmaceuticals, Inc. |
Certain substituted amides, method of making, and method of use thereof
|
|
DK2319830T3
(en)
*
|
2008-08-13 |
2017-02-13 |
Mitsui Chemicals Agro Inc |
Amide derivative, pesticide containing the amide derivative and use of the pesticide
|
|
AU2009289378A1
(en)
|
2008-09-02 |
2010-03-11 |
Boehringer Ingelheim International Gmbh |
Novel benzamides, production thereof, and use thereof as medicaments
|
|
WO2010056875A1
(en)
|
2008-11-12 |
2010-05-20 |
Cgi Pharmaceuticals, Inc. |
Pyridazinones and their use as btk inhibitors
|
|
IN2012DN02493A
(2)
|
2009-09-03 |
2015-08-28 |
Allergan Inc |
|
|
US9029359B2
(en)
|
2009-09-04 |
2015-05-12 |
Biogen Idec Ma, Inc. |
Heteroaryl Btk inhibitors
|
|
US9180127B2
(en)
*
|
2009-12-29 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
|
JP5985473B2
(ja)
|
2010-07-13 |
2016-09-06 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
ＩＲＡＫ４モジュレーターとしてのピラゾロ［１，５ａ］ピリミジン及びチエノ［３，２ｂ］ピリミジン誘導体
|
|
AU2011328237A1
(en)
|
2010-11-09 |
2013-05-23 |
Cellzome Limited |
Pyridine compounds and aza analogues thereof as TYK2 inhibitors
|
|
US20140080810A1
(en)
|
2010-11-15 |
2014-03-20 |
Exelixis, Inc. |
Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture
|
|
WO2012161877A1
(en)
*
|
2011-05-23 |
2012-11-29 |
Merck Patent Gmbh |
Pyridine-and pyrazine derivatives
|
|
KR20180084153A
(ko)
*
|
2011-06-10 |
2018-07-24 |
메르크 파텐트 게엠베하 |
Btk 억제 활성을 갖는 피리미딘 및 피리딘 화합물의 조성물 및 제조방법
|
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
|
MX2014003994A
(es)
*
|
2011-10-03 |
2014-05-07 |
Syngenta Participations Ag |
Derivados insecticidas de 2-metoxobenzamida.
|
|
JP2014528451A
(ja)
|
2011-10-04 |
2014-10-27 |
ギリアード カリストガ エルエルシー |
Ｐｉ３ｋの新規キノキサリン阻害剤
|
|
MX2014005289A
(es)
|
2011-11-03 |
2014-05-30 |
Hoffmann La Roche |
Compuestos de piperazina alquilados.
|
|
CA2856291C
(en)
|
2011-11-17 |
2020-08-11 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-jun-n-terminal kinase (jnk)
|
|
DK2790705T3
(en)
|
2011-12-15 |
2018-03-12 |
Novartis Ag |
Use of inhibitors of the activity or function of PI3K
|
|
CN103405429A
(zh)
*
|
2013-08-22 |
2013-11-27 |
中国药科大学 |
一类vegfr-2抑制剂及其用途
|
|
WO2015069287A1
(en)
|
2013-11-08 |
2015-05-14 |
Allergan, Inc. |
Compounds as tyrosine kinase modulators
|
|
US9856223B2
(en)
|
2013-12-13 |
2018-01-02 |
Dana-Farber Cancer Institute, Inc. |
Methods to treat lymphoplasmacytic lymphoma
|
|
EP3079682A4
(en)
|
2013-12-13 |
2017-08-30 |
Dana-Farber Cancer Institute, Inc. |
Methods to treat lymphoplasmacytic lymphoma
|
|
US10112957B2
(en)
|
2014-10-22 |
2018-10-30 |
Dana-Farber Cancer Institute, Inc. |
Thiazolyl-containing compounds for treating proliferative diseases
|